It is particularly noteworthy that MCP-1 serum levels were highest in patients with fulminant hepatic failure and fatal outcome compared to patients with acute non-fulminant hepatitis and favourable outcome [39]. This evidence concerns the gene CCL2 and Fulminant hepatic failure.